Measured GFR does not outperform estimated GFR in predicting CKD-related complications

Chi Yuan Hsu, Kathleen Propert, Dawei Xie, Lee Hamm, Jiang He, Edgar R Miller, Akinlolu Ojo, Michael Shlipak, Valerie Teal, Raymond Townsend, Matthew Weir, Jillian Wilson, Harold Feldman

Research output: Contribution to journalArticle

Abstract

Although many assume that measurement of glomerular filtration rate (GFR) using a marker such as iothalamate (iGFR) is superior to equation-estimated GFR (eGFR), each of these methods has distinct disadvantages. Because physicians often use renal function to guide the screening for various CKD-associated complications, one method to compare the clinical utility of iGFR and eGFR is to determine the strength of their association with CKD-associated comorbidities. Using a subset of 1214 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study, we determined the cross-sectional associations between known complications of CKD and iGFR, eGFR estimated from serum creatinine (eGFR-Cr), and eGFR estimated from cystatin C (eGFR-cysC). We found that none of the measures of renal function strongly associated with CKD complications and that the relative strengths of associations varied according to the outcome of interest. For example, iGFR demonstrated better discrimination than eGFR-Cr and eGFR-cysC for outcomes of anemia and hemoglobin concentration; however, both eGFR-Cr and eGFR-cysC demonstrated better discrimination than iGFR for outcomes of hyperphosphatemia and phosphorus level. iGFR and eGFR had similar strengths of association with hyperkalemia/potassium level and with metabolic acidosis/bicarbonate level. In conclusion, iothalamate measurement of GFR is not consistently superior to equation-based estimations of GFR in explaining CKD-related comorbidities. These results raise questions regarding the conventional view that iGFR is the "gold standard" measure of kidney function.

Original languageEnglish (US)
Pages (from-to)1931-1937
Number of pages7
JournalJournal of the American Society of Nephrology
Volume22
Issue number10
DOIs
StatePublished - Oct 2011

Fingerprint

Glomerular Filtration Rate
Iothalamic Acid
Kidney
Comorbidity
Hyperphosphatemia
Cystatin C
Hyperkalemia
Bicarbonates
Acidosis
Chronic Renal Insufficiency
Phosphorus
Anemia
Creatinine
Potassium
Hemoglobins
Cohort Studies
Physicians
Serum

ASJC Scopus subject areas

  • Nephrology

Cite this

Measured GFR does not outperform estimated GFR in predicting CKD-related complications. / Hsu, Chi Yuan; Propert, Kathleen; Xie, Dawei; Hamm, Lee; He, Jiang; Miller, Edgar R; Ojo, Akinlolu; Shlipak, Michael; Teal, Valerie; Townsend, Raymond; Weir, Matthew; Wilson, Jillian; Feldman, Harold.

In: Journal of the American Society of Nephrology, Vol. 22, No. 10, 10.2011, p. 1931-1937.

Research output: Contribution to journalArticle

Hsu, CY, Propert, K, Xie, D, Hamm, L, He, J, Miller, ER, Ojo, A, Shlipak, M, Teal, V, Townsend, R, Weir, M, Wilson, J & Feldman, H 2011, 'Measured GFR does not outperform estimated GFR in predicting CKD-related complications', Journal of the American Society of Nephrology, vol. 22, no. 10, pp. 1931-1937. https://doi.org/10.1681/ASN.2010101077
Hsu, Chi Yuan ; Propert, Kathleen ; Xie, Dawei ; Hamm, Lee ; He, Jiang ; Miller, Edgar R ; Ojo, Akinlolu ; Shlipak, Michael ; Teal, Valerie ; Townsend, Raymond ; Weir, Matthew ; Wilson, Jillian ; Feldman, Harold. / Measured GFR does not outperform estimated GFR in predicting CKD-related complications. In: Journal of the American Society of Nephrology. 2011 ; Vol. 22, No. 10. pp. 1931-1937.
@article{c343b7bb44404d9482e29080948ce5cf,
title = "Measured GFR does not outperform estimated GFR in predicting CKD-related complications",
abstract = "Although many assume that measurement of glomerular filtration rate (GFR) using a marker such as iothalamate (iGFR) is superior to equation-estimated GFR (eGFR), each of these methods has distinct disadvantages. Because physicians often use renal function to guide the screening for various CKD-associated complications, one method to compare the clinical utility of iGFR and eGFR is to determine the strength of their association with CKD-associated comorbidities. Using a subset of 1214 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study, we determined the cross-sectional associations between known complications of CKD and iGFR, eGFR estimated from serum creatinine (eGFR-Cr), and eGFR estimated from cystatin C (eGFR-cysC). We found that none of the measures of renal function strongly associated with CKD complications and that the relative strengths of associations varied according to the outcome of interest. For example, iGFR demonstrated better discrimination than eGFR-Cr and eGFR-cysC for outcomes of anemia and hemoglobin concentration; however, both eGFR-Cr and eGFR-cysC demonstrated better discrimination than iGFR for outcomes of hyperphosphatemia and phosphorus level. iGFR and eGFR had similar strengths of association with hyperkalemia/potassium level and with metabolic acidosis/bicarbonate level. In conclusion, iothalamate measurement of GFR is not consistently superior to equation-based estimations of GFR in explaining CKD-related comorbidities. These results raise questions regarding the conventional view that iGFR is the {"}gold standard{"} measure of kidney function.",
author = "Hsu, {Chi Yuan} and Kathleen Propert and Dawei Xie and Lee Hamm and Jiang He and Miller, {Edgar R} and Akinlolu Ojo and Michael Shlipak and Valerie Teal and Raymond Townsend and Matthew Weir and Jillian Wilson and Harold Feldman",
year = "2011",
month = "10",
doi = "10.1681/ASN.2010101077",
language = "English (US)",
volume = "22",
pages = "1931--1937",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "10",

}

TY - JOUR

T1 - Measured GFR does not outperform estimated GFR in predicting CKD-related complications

AU - Hsu, Chi Yuan

AU - Propert, Kathleen

AU - Xie, Dawei

AU - Hamm, Lee

AU - He, Jiang

AU - Miller, Edgar R

AU - Ojo, Akinlolu

AU - Shlipak, Michael

AU - Teal, Valerie

AU - Townsend, Raymond

AU - Weir, Matthew

AU - Wilson, Jillian

AU - Feldman, Harold

PY - 2011/10

Y1 - 2011/10

N2 - Although many assume that measurement of glomerular filtration rate (GFR) using a marker such as iothalamate (iGFR) is superior to equation-estimated GFR (eGFR), each of these methods has distinct disadvantages. Because physicians often use renal function to guide the screening for various CKD-associated complications, one method to compare the clinical utility of iGFR and eGFR is to determine the strength of their association with CKD-associated comorbidities. Using a subset of 1214 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study, we determined the cross-sectional associations between known complications of CKD and iGFR, eGFR estimated from serum creatinine (eGFR-Cr), and eGFR estimated from cystatin C (eGFR-cysC). We found that none of the measures of renal function strongly associated with CKD complications and that the relative strengths of associations varied according to the outcome of interest. For example, iGFR demonstrated better discrimination than eGFR-Cr and eGFR-cysC for outcomes of anemia and hemoglobin concentration; however, both eGFR-Cr and eGFR-cysC demonstrated better discrimination than iGFR for outcomes of hyperphosphatemia and phosphorus level. iGFR and eGFR had similar strengths of association with hyperkalemia/potassium level and with metabolic acidosis/bicarbonate level. In conclusion, iothalamate measurement of GFR is not consistently superior to equation-based estimations of GFR in explaining CKD-related comorbidities. These results raise questions regarding the conventional view that iGFR is the "gold standard" measure of kidney function.

AB - Although many assume that measurement of glomerular filtration rate (GFR) using a marker such as iothalamate (iGFR) is superior to equation-estimated GFR (eGFR), each of these methods has distinct disadvantages. Because physicians often use renal function to guide the screening for various CKD-associated complications, one method to compare the clinical utility of iGFR and eGFR is to determine the strength of their association with CKD-associated comorbidities. Using a subset of 1214 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study, we determined the cross-sectional associations between known complications of CKD and iGFR, eGFR estimated from serum creatinine (eGFR-Cr), and eGFR estimated from cystatin C (eGFR-cysC). We found that none of the measures of renal function strongly associated with CKD complications and that the relative strengths of associations varied according to the outcome of interest. For example, iGFR demonstrated better discrimination than eGFR-Cr and eGFR-cysC for outcomes of anemia and hemoglobin concentration; however, both eGFR-Cr and eGFR-cysC demonstrated better discrimination than iGFR for outcomes of hyperphosphatemia and phosphorus level. iGFR and eGFR had similar strengths of association with hyperkalemia/potassium level and with metabolic acidosis/bicarbonate level. In conclusion, iothalamate measurement of GFR is not consistently superior to equation-based estimations of GFR in explaining CKD-related comorbidities. These results raise questions regarding the conventional view that iGFR is the "gold standard" measure of kidney function.

UR - http://www.scopus.com/inward/record.url?scp=80053504925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053504925&partnerID=8YFLogxK

U2 - 10.1681/ASN.2010101077

DO - 10.1681/ASN.2010101077

M3 - Article

C2 - 21921144

AN - SCOPUS:80053504925

VL - 22

SP - 1931

EP - 1937

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 10

ER -